• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于效用的痴呆患者评估工具:系统评价和荟萃回归分析。

Utility-Based Instruments for People with Dementia: A Systematic Review and Meta-Regression Analysis.

机构信息

Centre for Applied Health Economics, Menzies Health Institute Queensland, School of Medicine, Griffith University, Nathan, Queensland, Australia.

Centre for Applied Health Economics, Menzies Health Institute Queensland, School of Medicine, Griffith University, Nathan, Queensland, Australia; The NHMRC Cognitive Decline Partnership Centre, Sydney, New South Wales, Australia.

出版信息

Value Health. 2018 Apr;21(4):471-481. doi: 10.1016/j.jval.2017.09.005. Epub 2017 Nov 7.

DOI:10.1016/j.jval.2017.09.005
PMID:29680105
Abstract

BACKGROUND

Several utility-based instruments have been applied in cost-utility analysis to assess health state values for people with dementia. Nevertheless, concerns and uncertainty regarding their performance for people with dementia have been raised.

OBJECTIVES

To assess the performance of available utility-based instruments for people with dementia by comparing their psychometric properties and to explore factors that cause variations in the reported health state values generated from those instruments by conducting meta-regression analyses.

METHODS

A literature search was conducted and psychometric properties were synthesized to demonstrate the overall performance of each instrument. When available, health state values and variables such as the type of instrument and cognitive impairment levels were extracted from each article. A meta-regression analysis was undertaken and available covariates were included in the models.

RESULTS

A total of 64 studies providing preference-based values were identified and included. The EuroQol five-dimension questionnaire demonstrated the best combination of feasibility, reliability, and validity. Meta-regression analyses suggested that significant differences exist between instruments, type of respondents, and mode of administration and the variations in estimated utility values had influences on incremental quality-adjusted life-year calculation.

CONCLUSIONS

This review finds that the EuroQol five-dimension questionnaire is the most valid utility-based instrument for people with dementia, but should be replaced by others under certain circumstances. Although no utility estimates were reported in the article, the meta-regression analyses that examined variations in utility estimates produced by different instruments impact on cost-utility analysis, potentially altering the decision-making process in some circumstances.

摘要

背景

已有多种基于效用的工具被应用于成本效用分析,以评估痴呆患者的健康状态值。然而,针对这些工具在痴呆患者中的表现,人们仍存在担忧和不确定性。

目的

通过比较其心理测量特性,评估现有基于效用的工具在痴呆患者中的表现,并通过进行荟萃回归分析,探索导致这些工具报告的健康状态值存在差异的因素。

方法

进行文献检索并综合心理测量特性,以展示每个工具的整体表现。当有可用数据时,从每篇文章中提取健康状态值和变量,如工具类型和认知障碍程度。进行荟萃回归分析,并将可用的协变量纳入模型。

结果

共确定并纳入了 64 项提供偏好值的研究。EuroQol 五维问卷在可行性、可靠性和有效性方面表现最佳。荟萃回归分析表明,不同工具之间、受访者类型以及管理方式存在显著差异,且估计效用值的差异对增量质量调整生命年的计算有影响。

结论

本综述发现,EuroQol 五维问卷是最适合痴呆患者的基于效用的工具,但在某些情况下需要被其他工具替代。尽管文章中没有报告效用估计值,但荟萃回归分析检查了不同工具产生的效用估计值的差异对成本效用分析的影响,在某些情况下可能会改变决策过程。

相似文献

1
Utility-Based Instruments for People with Dementia: A Systematic Review and Meta-Regression Analysis.基于效用的痴呆患者评估工具:系统评价和荟萃回归分析。
Value Health. 2018 Apr;21(4):471-481. doi: 10.1016/j.jval.2017.09.005. Epub 2017 Nov 7.
2
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
5
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
6
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.多奈哌齐、卡巴拉汀、加兰他敏和美金刚用于治疗阿尔茨海默病的临床疗效及成本效益
Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. doi: 10.3310/hta10010.
9
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
10
Reminiscence therapy for dementia.痴呆症的回忆疗法
Cochrane Database Syst Rev. 2018 Mar 1;3(3):CD001120. doi: 10.1002/14651858.CD001120.pub3.

引用本文的文献

1
Self-reported quality of life in progressive cognitive decline-let's not throw the baby out with the bathwater.进行性认知衰退中自我报告的生活质量——我们不要因噎废食。
Qual Life Res. 2025 Jun 27. doi: 10.1007/s11136-025-04009-7.
2
Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports.绘制痴呆症患者的EQ-5D-5L效用值:整合自我报告和代理报告。
Value Health. 2025 Aug;28(8):1204-1212. doi: 10.1016/j.jval.2025.05.009. Epub 2025 Jun 5.
3
Enhancing HRQoL assessment for economic evaluation in dementia populations.加强痴呆人群经济评估中的健康相关生活质量评估。
Alzheimers Dement (N Y). 2025 Mar 10;11(1):e70061. doi: 10.1002/trc2.70061. eCollection 2025 Jan-Mar.
4
Cost-Effectiveness of the Tailored Activity Programme for Person With Dementia-Caregiver Dyads: A Markov Model.针对痴呆症患者-照顾者二元组的定制活动计划的成本效益:一个马尔可夫模型。
Int J Geriatr Psychiatry. 2025 Feb;40(2):e70049. doi: 10.1002/gps.70049.
5
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment.基于模型的痴呆干预措施经济学评价:一项更新的系统评价和质量评估。
Appl Health Econ Health Policy. 2024 Jul;22(4):503-525. doi: 10.1007/s40258-024-00878-0. Epub 2024 Mar 30.
6
How do quantitative studies involving people with dementia report experiences of standardised data collection? A narrative synthesis of NIHR published studies.涉及痴呆症患者的定量研究如何报告标准化数据收集的经验?基于 NIHR 已发表研究的叙述性综合。
BMC Med Res Methodol. 2024 Feb 16;24(1):43. doi: 10.1186/s12874-024-02148-y.
7
Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis.主观认知衰退和轻度认知障碍患者的健康相关生活质量:一项纵向队列分析。
Alzheimers Res Ther. 2023 Nov 15;15(1):200. doi: 10.1186/s13195-023-01344-0.
8
Standardised data collection from people with dementia over the telephone: A qualitative study of the experience of DETERMIND programme researchers in a pandemic.电话中对痴呆症患者进行标准化数据收集:DETERMIND 项目研究人员在大流行期间的经验定性研究。
Dementia (London). 2023 Nov;22(8):1718-1737. doi: 10.1177/14713012231190585. Epub 2023 Jul 26.
9
Item distribution, scalability and internal consistency of the QUALIDEM quality of life assessment for patients with dementia in acute hospital settings.用于急性医院环境中痴呆患者的 QUALIDEM 生活质量评估的项目分布、可扩展性和内部一致性。
Health Qual Life Outcomes. 2023 Jan 31;21(1):12. doi: 10.1186/s12955-023-02094-1.
10
Convergent validity of EQ-5D with core outcomes in dementia: a systematic review.痴呆症中 EQ-5D 与核心结局的汇聚效度:系统评价。
Health Qual Life Outcomes. 2022 Nov 19;20(1):152. doi: 10.1186/s12955-022-02062-1.